PT2512236T - Método aperfeiçoado de administração de beta-hidroxi-beta-metilbutirato (hmb) - Google Patents
Método aperfeiçoado de administração de beta-hidroxi-beta-metilbutirato (hmb)Info
- Publication number
- PT2512236T PT2512236T PT108383555T PT10838355T PT2512236T PT 2512236 T PT2512236 T PT 2512236T PT 108383555 T PT108383555 T PT 108383555T PT 10838355 T PT10838355 T PT 10838355T PT 2512236 T PT2512236 T PT 2512236T
- Authority
- PT
- Portugal
- Prior art keywords
- beta
- hmb
- methylbutyrate
- hydroxy
- improved method
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28785709P | 2009-12-18 | 2009-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2512236T true PT2512236T (pt) | 2016-12-29 |
Family
ID=44167737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT108383555T PT2512236T (pt) | 2009-12-18 | 2010-12-20 | Método aperfeiçoado de administração de beta-hidroxi-beta-metilbutirato (hmb) |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20120053240A1 (https=) |
| EP (1) | EP2512236B1 (https=) |
| JP (2) | JP6077857B2 (https=) |
| CN (1) | CN102762097B (https=) |
| CA (1) | CA2784836C (https=) |
| DK (1) | DK2512236T3 (https=) |
| ES (1) | ES2608483T3 (https=) |
| HU (1) | HUE032486T2 (https=) |
| PL (1) | PL2512236T3 (https=) |
| PT (1) | PT2512236T (https=) |
| WO (1) | WO2011075741A1 (https=) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2631597C2 (ru) * | 2011-07-15 | 2017-09-25 | Нусерт Сайенсиз, Инк. | Композиции и способы модулирования метаболических путей |
| US10092590B2 (en) * | 2012-09-10 | 2018-10-09 | Metabolic Technologies, Inc. | Composition of HMB and ATP and methods of use |
| US20140272000A1 (en) * | 2013-03-14 | 2014-09-18 | Metabolic Technologies, Inc. | Liquids and Foodstuffs Containing beta-hydroxy-beta-methylbutyrate (HMB) in the Free Acid Form and Methods of Manufacturing or Producing the Same |
| EP2993994A4 (en) * | 2013-03-14 | 2016-11-23 | Metabolic Technologies Inc | LIQUIDS AND FOODS WITH BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) IN A FREE ACID FORM |
| JP2016513701A (ja) | 2013-03-14 | 2016-05-16 | アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ | 長期身体不活動に関連するインスリン抵抗性の治療 |
| CN105188417B (zh) * | 2013-03-15 | 2017-08-08 | 雅培制药有限公司 | 包括β‑羟基‑β‑甲基丁酸钙、酪蛋白磷酸肽和蛋白质的营养组合物 |
| US20150057350A1 (en) * | 2013-08-23 | 2015-02-26 | Abbott Laboratories | Fibrosis biomarkers and methods of using same |
| EP3082778B1 (en) * | 2013-12-18 | 2019-04-03 | Capsugel Belgium NV | Stable liquid filled hard capsule comprising beta-hydroxy-beta-methylbutyric acid |
| WO2015105981A2 (en) * | 2014-01-09 | 2015-07-16 | Abbott Laboratories | Conditional essentiality of hmb |
| EP3099411A4 (en) | 2014-01-28 | 2017-09-20 | The Methodist Hospital | Single-cell pipette assembly comprising single-cell pipette handle and single-cell pipette tip |
| JP6309287B2 (ja) * | 2014-01-29 | 2018-04-11 | 協和発酵バイオ株式会社 | ３−ヒドロキシ−３−メチル酪酸カルシウム含有飲料 |
| JP6480964B2 (ja) * | 2014-03-14 | 2019-03-13 | メタボリック・テクノロジーズ，インコーポレーテッド | 遊離酸形のβ−ヒドロキシ−β−メチル酪酸（ＨＭＢ）を含有する液体及び食品ならびにその製造法 |
| US20160184248A1 (en) * | 2014-12-15 | 2016-06-30 | University Of Central Florida Research Foundation Inc. | Compositions and methods of use of -hydroxy-methylbutyrate (hmb) resulting in an acute endocrine response |
| WO2016196637A1 (en) * | 2015-06-01 | 2016-12-08 | Metabolic Technologies, Inc. | Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (hmb) for decreasing fat mass |
| US12208073B2 (en) | 2015-09-16 | 2025-01-28 | Metabolic Technologies, LLC | Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) for enhancing recovery from soft tissue trauma |
| PT3349745T (pt) * | 2015-09-16 | 2024-03-18 | Metabolic Tech Inc | Composições e métodos de utilização de beta-hidroxi-beta metilbutirato (hmb) para melhorar a recuperação de traumatismos de tecidos moles |
| AU2016353003B2 (en) | 2015-11-10 | 2021-06-10 | Metabolic Technologies, Inc. | Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) as an animal feed additive |
| CN108697675A (zh) * | 2016-01-13 | 2018-10-23 | 代谢科技有限公司 | 用于关节稳定性的β-羟基-β-甲基丁酸(HMB)的组合物和使用方法 |
| WO2017127675A1 (en) | 2016-01-21 | 2017-07-27 | Metabolic Technololgies, Inc. | COMPOSITIONS AND METHODS OF USE OF β-HYDROXY-β-METHYLBUTYRATE (HMB) FOR MODULATING AUTOPHAGY AND LIPOPHAGY |
| US11103470B2 (en) | 2017-11-22 | 2021-08-31 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US11241403B2 (en) | 2016-03-11 | 2022-02-08 | Axcess Global Sciences, Llc | Beta-hydroxybutyrate mixed salt compositions and methods of use |
| US20230346721A1 (en) | 2018-04-18 | 2023-11-02 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies |
| US10925843B2 (en) | 2018-04-18 | 2021-02-23 | Axcess Global Sciences, Llc | Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate |
| US12329734B2 (en) | 2017-12-19 | 2025-06-17 | Axcess Global Sciences, Llc | Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow |
| US12109182B2 (en) | 2016-04-19 | 2024-10-08 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| US12521378B2 (en) | 2016-04-19 | 2026-01-13 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans |
| US12533346B2 (en) | 2016-04-19 | 2026-01-27 | Axcess Global Sciences, Llc | Administration of berberine metabolites |
| US11202769B2 (en) | 2017-11-22 | 2021-12-21 | Axcess Global Sciences, Llc | Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function |
| US11806324B2 (en) | 2018-04-18 | 2023-11-07 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies |
| US12599579B2 (en) | 2016-04-19 | 2026-04-14 | Axcess Global Sciences, Llc | Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids |
| US11944598B2 (en) | 2017-12-19 | 2024-04-02 | Axcess Global Sciences, Llc | Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer |
| US12496283B2 (en) | 2016-04-19 | 2025-12-16 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| WO2017205673A1 (en) * | 2016-05-25 | 2017-11-30 | TSI Group Ltd. | Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules |
| US10588877B2 (en) | 2016-07-21 | 2020-03-17 | Savind, Inc. | Compositions comprising β-hydroxybutyric acid and salt, and methods of using the same |
| US12370159B2 (en) * | 2016-10-21 | 2025-07-29 | Metabolic Technologies, LLC | Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics |
| HUE069527T2 (hu) | 2016-10-21 | 2025-03-28 | Metabolic Tech Llc | Béta-hidroxi-béta-metil-butirát (HMB) és probiotikumok kompozíciói és alkalmazási eljárásai |
| JP7022420B2 (ja) * | 2017-06-30 | 2022-02-18 | 株式会社東洋新薬 | 経口組成物 |
| US12090129B2 (en) | 2017-11-22 | 2024-09-17 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| JP2021509686A (ja) * | 2018-01-05 | 2021-04-01 | テキサス・テック・ユニバーシティー・オフィス・オブ・リサーチ・コマーシャライゼーション | 間欠性絶食に関連するβ−ヒドロキシ−β−メチルブチレート（ＨＭＢ）の組成物およびその使用法 |
| US11419836B2 (en) | 2019-02-13 | 2022-08-23 | Axcess Global Sciences, Llc | Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions |
| US10888576B2 (en) | 2018-10-08 | 2021-01-12 | Metabolic Technologies, Inc. | Composition of HMB and ATP and methods of use |
| US12472200B2 (en) | 2019-05-15 | 2025-11-18 | Axcess Global Sciences, Llc | Autobiotic compositions and method for promoting healthy gut microbiome |
| US12167993B2 (en) | 2019-06-21 | 2024-12-17 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US11969430B1 (en) | 2023-03-10 | 2024-04-30 | Axcess Global Sciences, Llc | Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance |
| US11950616B2 (en) | 2019-06-21 | 2024-04-09 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US12186297B2 (en) * | 2020-08-26 | 2025-01-07 | Axcess Global Sciences, Llc | Compositions and methods for increasing lean-to-fat mass ratio |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4857552A (en) * | 1988-06-08 | 1989-08-15 | E. I. Du Pont De Nemours And Co. | Stable pharmaceutical composition |
| US5087472A (en) * | 1990-01-30 | 1992-02-11 | Iowa State University Research Foundation, Inc. | Feed compositions for domestics animals containing hydroxymethylbutyrate |
| US5028440A (en) * | 1990-01-30 | 1991-07-02 | Iowa State University Research Foundation, Inc. | Method of raising meat producing animals to increase lean tissue development |
| US4992470A (en) * | 1990-02-08 | 1991-02-12 | Iowa State University Research Foundation, Inc. | Method of enhancing immune response of mammals |
| US5348979A (en) * | 1992-12-23 | 1994-09-20 | Iowa State University Research Foundation Inc. | Method of promoting nitrogen retention in humans |
| US6103764A (en) * | 1997-11-07 | 2000-08-15 | Iowa State University Research Foundation, Inc. | Method for increasing the aerobic capacity of muscle |
| US6031000A (en) * | 1998-06-23 | 2000-02-29 | Iowa State University Research Foundation, Inc. | Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
| US20010008641A1 (en) * | 1998-11-25 | 2001-07-19 | R. Douglas Krotzer | Nutritionally active composition for bodybuilding |
| DE60234780D1 (de) * | 2001-08-31 | 2010-01-28 | Univ Rutgers | Verfahren zur behandlung von krankheiten mit pflanzenextrakten |
| DE10215007A1 (de) * | 2002-04-05 | 2003-10-16 | Degussa Bioactives Deutschland | Verwendung von Kreatinpyruvat zur Steigerung der Ausdauer bei hochintensiven körperlichen Intervallbelastungen |
| US20040220266A1 (en) * | 2002-09-09 | 2004-11-04 | Wiley David B. | Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives |
| EP1750527A1 (en) * | 2004-03-11 | 2007-02-14 | Wiley Organics, Inc. | Compositions and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives |
| US20050215640A1 (en) * | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
| WO2007056176A2 (en) * | 2005-11-03 | 2007-05-18 | Southwest Immunology, Inc. | Compositions for preventing and reducing delayed onset muscle soreness |
| WO2010068696A1 (en) * | 2008-12-09 | 2010-06-17 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
| JP2009155336A (ja) * | 2009-03-31 | 2009-07-16 | Tsujido Chemical Corp | 治療剤 |
-
2010
- 2010-12-20 EP EP10838355.5A patent/EP2512236B1/en active Active
- 2010-12-20 ES ES10838355.5T patent/ES2608483T3/es active Active
- 2010-12-20 HU HUE10838355A patent/HUE032486T2/en unknown
- 2010-12-20 PL PL10838355T patent/PL2512236T3/pl unknown
- 2010-12-20 PT PT108383555T patent/PT2512236T/pt unknown
- 2010-12-20 US US12/973,803 patent/US20120053240A1/en not_active Abandoned
- 2010-12-20 CA CA2784836A patent/CA2784836C/en active Active
- 2010-12-20 CN CN201080064031.3A patent/CN102762097B/zh active Active
- 2010-12-20 WO PCT/US2010/061367 patent/WO2011075741A1/en not_active Ceased
- 2010-12-20 JP JP2012544948A patent/JP6077857B2/ja active Active
- 2010-12-20 DK DK10838355.5T patent/DK2512236T3/en active
-
2015
- 2015-09-25 JP JP2015188107A patent/JP2016026181A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN102762097A (zh) | 2012-10-31 |
| EP2512236A4 (en) | 2013-06-19 |
| US20120053240A1 (en) | 2012-03-01 |
| JP2013515009A (ja) | 2013-05-02 |
| ES2608483T3 (es) | 2017-04-11 |
| JP2016026181A (ja) | 2016-02-12 |
| PL2512236T3 (pl) | 2017-06-30 |
| DK2512236T3 (en) | 2017-01-16 |
| CA2784836A1 (en) | 2011-06-23 |
| CA2784836C (en) | 2019-08-20 |
| CN102762097B (zh) | 2015-06-17 |
| JP6077857B2 (ja) | 2017-02-08 |
| WO2011075741A1 (en) | 2011-06-23 |
| HUE032486T2 (en) | 2018-05-02 |
| EP2512236A1 (en) | 2012-10-24 |
| EP2512236B1 (en) | 2016-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2512236T3 (pl) | Ulepszony sposób podawania beta-hydroksy-beta-metylomaślanu (hmb) | |
| AP3155A (en) | Methods of administering pirfenidone therapy | |
| IL214919A0 (en) | Method for therapeutic use | |
| GB201018147D0 (en) | Method of treatment | |
| SI2427477T1 (sl) | Postopek priprave ciklopeptidov | |
| ZA201109278B (en) | Method for treatment of diseases | |
| GB201003920D0 (en) | Method of treatment | |
| IL213955A (en) | Method for improved biological activity of pharmaceutical preparations | |
| GB0908101D0 (en) | Treatment of stress | |
| GB201018149D0 (en) | Method of treatment | |
| EP2424539A4 (en) | PROCESS FOR TREATING DEPRESSION | |
| EP2404891A4 (en) | PROCESS FOR THE PREPARATION OF ACYLBENZENES | |
| EP2585103A4 (en) | METHOD OF TREATMENT | |
| GB201020015D0 (en) | Method of treatment | |
| AP2984A (en) | An arteether injection for treatment of malaria | |
| GB0904164D0 (en) | Method of treatment | |
| GB0921823D0 (en) | Method of treatment | |
| GB0909807D0 (en) | Method of treatment | |
| GB0920070D0 (en) | Method of processing blood | |
| GB201000318D0 (en) | Method of treatment | |
| GB201005071D0 (en) | Method of treatment | |
| GB201003917D0 (en) | Method of treatment | |
| GB201019936D0 (en) | Therapeutic method | |
| GB0915895D0 (en) | Method of cleansing | |
| AU2009903360A0 (en) | Method of Treatment |